Ahsan Achtchi, DO
Interventional Cardiology · Dalton, GANPI 1821256496
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Inari Medical, Inc. accounts for 86.4% of it on its own, with 44 other manufacturers making up the rest. Reporting peaked in 2021 at $36,513 and has fallen 84.7% since, to $5,602 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 439 payments — averaging $275.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$104K
- Stryker$3K
- Shockwave Medical, Inc$2K
- Medtronic$2K
- Boston Scientific$1K
- Cardiovascular Systems Inc.$1K
- plus $7K from 39 others
What the payments were for
- Consulting fees$65,75054%
- Speaking & faculty fees$30,00025%
- Travel & lodging$7,4706%
- Food & beverage$17,55315%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$127,813
- FLOWTRIEVER CATHETER, S$61,813
- FlowTriever$11,902
- ClotTriever$11,902
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$985
- Peripheral Orbital Atherectomy System$827
- OPTIMIZER$649
- GENERAL VASCULAR INTERVENTION$616
- Vascular Lithotripsy$562
- SYMPLICITY G3$541
- Barostim Neo System$535
- Impella$286
- Optis Coronary Imaging System$258
- AngioVac$234
- Resolute$172
- Indigo System$150
- Abre$149
- XARELTO$141
- ANGIOJET$141
- EKOSONIC$140
How this compares
$120,784 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 229 | $225,755 |
| Repatha SureclickEvolocumab | 73 | $80,396 |
| EntrestoSacubitril/Valsartan | 52 | $54,798 |
| XareltoRivaroxaban | 51 | $51,809 |
| JardianceEmpagliflozin | 22 | $29,990 |
| BrilintaTicagrelor | 23 | $21,912 |
| Atorvastatin Calcium | 312 | $3,186 |
| Metoprolol Succinate | 108 | $1,522 |
| Rosuvastatin Calcium | 118 | $1,336 |
| Losartan Potassium | 115 | $1,075 |
| Eplerenone | 11 | $991 |
| Ranolazine ErRanolazine | 18 | $899 |
| ClopidogrelClopidogrel Bisulfate | 82 | $872 |
| Valsartan | 41 | $821 |
| Amiodarone Hcl | 12 | $811 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $323 | $225,755229 claims |
| NovartisEntresto | $657 | $54,79852 claims |
| Johnson & JohnsonXarelto | $547 | $51,80951 claims |
| Boehringer IngelheimJardiance | $384 | $29,99022 claims |
| AstraZenecaBrilinta | $52 | $21,91223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Dalton
- Yeunjung KimDalton$107K
- Eric GuerraDalton$35K
- Tharmathai RamananDalton$23K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Salvatore ManninoMarietta$275K
- Megan CoylewrightCalhoun$271K
- Paul GuichardMarietta$260K
- Adam GreenbaumAtlanta$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.